New findings may help oncologists determine effectiveness of checkpoint inhibitors
In an article recently published in JCI Insight, researchers have identified checkpoint inhibitor resistance mechanisms in many solid tumor cancers, including melanoma, lung cancer and breast cancer. Randall S. Davis, M.D., professor at the University of Alabama and senior scientist in the O'Neal Comprehensive Cancer Center, served as the paper's co-senior author.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063